2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Testamentary Capacity Assessment Tool (TCAT): An update report

P. Voskou, A. Douzenis, A. Economou, S. Papageorgiou (Athens, Greece)
Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression

R. Bhome, A. Zarkali, G. Thomas, J. Iglesias, J. Cole, R. Weil (London, United Kingdom)
The 20-item Noise Pareidolia Task is uniquely sensitive to Visual Hallucinations in Parkinson’s Disease

T. Turner, F. Rodriguez-Porcel (Charleston, USA)
The acceptability of wearable devices to measure mobility in people with Parkinson’s Disease: observations from Mobilise-D

A. Keogh, L. Alcock, P. Brown, M. Brozgol, E. Gazit, C. Hansen, J. Hausdorff, W. Maetzler, L. Rochester, A. Yarnall, B. Caulfield (Dublin, Ireland)
The Achilles’ heel of a craftsman, a complication of Guillain-Barré Syndrome

S. Lopes, O. Costa, L. Costa, C. Machado, S. Varanda (Braga, Portugal)
The agreement between automated and expert FOG annotations during an at-home protocol: influence of dopaminergic medication and task

N. D'Cruz, D. Zoetewei, T. Herman, P. Ginis, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)
The anti-alpha-synuclein antibody Lu AF82422 binds to pathological alpha-synuclein species from human brains and inhibits seeded alpha-synuclein aggregation

P. Kallunki, K. Willén, F. Sotty, L. Buur, K. Bjerregaard-Andersen, M. Lubas, D. Damlund, M. Harndahl, K. Fog (Valby, Denmark)
The anti-alpha-synuclein antibody Lu AF82422 was safe and well tolerated in a FIH-SAD study in healthy subjects and patients with PD

L. Buur, J. Wiedemann, F. Larsen, F. Ben Alaya-Fourati, P. Kallunki, D. Ditlevsen, M. Sørensen, D. Meulien (Valby, Denmark)
The association of CSF sTREM2 with cognitive decline and its dynamic change in Parkinson’s disease: Analysis of the PPMI Cohort

Q. Qixiong, W. Hengming, W. Danlei, L. Jingyi, Q. Yi, Z. Jingwei, L. Jiangting (Wu han, China)
The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.

M. Boyce, A. Mccambridge, L. Bradnam, C. Canning, A. Verhagen (Ultimo, Australia)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z